Oppenheimer & Co. Inc.
19th Annual Healthcare Conference
November 3-4, 2008
The Waldorf-Astoria, New York
The two-day 2008 Oppenheimer Healthcare Conference will feature presentations by
140 public and private companies which are pioneering the pharmaceutical, biotechnology,
medical device, healthcare facility, health technology and distribution,
provider and service industries. Presentations will occur in five concurrent
tracks on Monday and six tracks on Tuesday.
Over the past eighteen years, this has become a highly valued investor
conference in this sector.
Company presentations will address topical issues such as Medicare and Medicaid reform, generic drug regulation, development of new pharmaceutical and biotechnology products, product safety and patent issues, cross-border reimportation, FDA policy, managed care issues and the current M&A environment. Each corporate session will include a formal presentation followed by a Q&A period in the same room. The conference will also include several informative panel discussions.
The conference handbook includes a description and contact information for each company. The conference attracts over 1500 industry executives and investors each year, making this a fruitful meeting for networking with continental breakfasts, continuous refreshments and luncheons available each day.
Clients of Oppenheimer & Co. and presenting company
representatives should register on the Oppenheimer website
www.opco.com/Conferences.
The registration fee for other members of the health care and investment
community is $995. To register, follow this
link.